Lisa M. Giles, Director at Durata Therapeutics, Inc. (DRTX), bought 500 shares at $8.25 ($4K) on 2012-08-06, disclosed to the SEC on 2014-01-23.
Open-market purchase of $4k DRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| DRTX | BUY | 2013-12-03 | $11K | — | Filing → |